Skip to navigation bar Skip to breadcrumbs Skip to page content
Envelope icon E-mail Updates Teal square Text size:  a A A

Hyperbilirubinemia: Screening Infants

Release Date: October 2009

Recommendation Summary

Summary of Recommendation

PopulationRecommendationGrade
(What's This?)
Infants

The U.S. Preventive Services Task Force (USPSTF) concludes that the evidence is insufficient to recommend screening infants for hyperbilirubinemia to prevent chronic bilirubin encephalopathy. 

The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of the service. Evidence is lacking, of poor quality, or conflicting, and the balance of benefits and harms cannot be determined.

Select "Clinical Considerations" for suggestions for practice when the evidence is insufficient.

Related Information for Consumers

Clinical Summary

Clinical summaries are one-page documents that provide guidance to primary care clinicians for using recommendations in practice.

This summary is intended for use by primary care clinicians.

 
Current as of: September 2013

Internet Citation: Recommendation Summary. U.S. Preventive Services Task Force. September 2014.
http://www.uspreventiveservicestaskforce.org/Page/Topic/recommendation-summary/hyperbilirubinemia-screening-infants

USPSTF Program Office Small blue square bullet icon  540 Gaither Road, Rockville, MD 20850